Lataa...
Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancer
The advent of targeted therapies has established new standards of care for defined molecular subsets of non-small cell lung cancer (NSCLC). Not only has this led to significant changes in the routine clinical management of lung cancer e.g., multiplexed genomic testing, but it has provided important...
Tallennettuna:
| Julkaisussa: | Ann Transl Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635263/ https://ncbi.nlm.nih.gov/pubmed/29057232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.08.42 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|